Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020-Reference-Cited by-同舟云学术

Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020

Published:2021-02 Issue:2 Volume:27 Page:628-631
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Yoshiyama Takashi,Saito Yasuki,Masuda Kunitsugu,Nakanishi Yoshiko,Kido Yasutoshi,Uchimura Kazuhiro,Mitarai Satoshi,Suzuki Tadaki,Nakagama Yu,Kubota Hiroshi,Satomi Maki,Uchikoba Sana,Ohnishi Makoto,Wakita Takaji,Kato Seiya,Kato Katsunobu

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference13 articles.

1. Ohhamazaki T. Coronavirus COVID-19 Japan case by each prefecture. 2020 [cited 2020 Jun 5]. https://jagjapan.maps.arcgis.com/apps/opsdashboard/index.html#/641eba7fef234a47880e1e1dc4de85ce

2. Ministry of Internal Affairs and Communications. Population estimates. 2019 Oct 1 [cited 2020 Jun 5]. https://www.stat.go.jp/data/jinsui/2019np/index.html

3. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho.;Bryan;J Clin Microbiol,2020

4. Abbott Core Laboratory. SARS-CoV-2 immunoassays. 2020 [cited 2020 Jun 17]. https://www.corelaboratory.abbott/us/en/offerings/segments/infectious-disease/sars-cov-2

5. F. Hoffman–La Roche Ltd. Elecsys® Anti-SARS-CoV-2. 2020 [cited 2020 Aug 19]. https://diagnostics.roche.com/no/en/products/params/elecsys-anti-sars-cov-2.html

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022;Emerging Infectious Diseases;2023-09

2. Estimating infection fatality risk and ascertainment bias of COVID-19 in Osaka, Japan from February 2020 to January 2022;Scientific Reports;2023-04-04

3. National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan;Influenza and Other Respiratory Viruses;2023-02

4. Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies;Journal of Global Health;2023-01-20

5. Age-stratified infection fatality rate of COVID-19 in the non-elderly population;Environmental Research;2023-01